Harshal Mamlekar

1PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 09, 2026
Real-World Outcomes With Low-Dose Dasatinib (50 mg) in Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Analysis of Efficacy and Safety.

Nandhini Gangadaran, Harshal Mamlekar, Souvik Saha

Pageof 1

Frequent Collaborators

1 joint publications

Nandhini Gangadaran

1 joint publications

Souvik Saha

1 joint publications

Rajesh Kashyap

1 joint publications

Sanjeev Yadav